The tumor suppressor SMAD4 (Mothers against decapentaplegic homolog 4) is inactivated in approximately 50%-60% of PDAC cases, disrupting the activation of the DLG1/YAP1 pathway. The gene discussed is SMAD4; the disease is neoplasm.